Open House Originale Rabattverträge 2025-02- Elvitegravir/Cobicistat/Emtricitabin/Tenofoviralafenamidfumarat (Genvoya(R))
Original notice title
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-02- Elvitegravir/Cobicistat/Emtricitabin/Tenofoviralafenamidfumarat (Genvoya(R))
Opportunity Score
Why this score?
Opportunity
15 / 100
Complexity
20 / 100
Risk factors
No estimated value, framework maximum, or lot values provided. Cannot estimate potential revenue.
Contract automatically ends upon patent expiry/loss of market exclusivity of Genvoya®. At that point, generic competiti...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Feb 2027
- Supply of the pharmaceutical product Genvoya® (Elvitegravir/Cobicistat/Emtricitabin/Tenofoviralafenamidfumarat) under discount agreements
- Participation open to any pharmaceutical company that markets or intends to market Genvoya® in Germany
Show full summary
Open House procedure by Techniker Krankenkasse (TK) and other German health insurers to conclude discount agreements under §130c SGB V for the active ingredient combination Elvitegravir/Cobicistat/Emtricitabin/Tenofoviralafenamidfumarat (Genvoya®). The procedure allows any eligible pharmaceutical company to join at any time during the 24-month contract period (01.03.2025 – 28.02.2027). No negotiation on terms; standard conditions apply. No exclusivity. The notice indicates this is not a public procurement subject to EU directives but published voluntarily. Value not disclosed.
Risks
No estimated value, framework maximum, or lot values provided. Cannot estimate potential revenue.
Contract automatically ends upon patent expiry/loss of market exclusivity of Genvoya®. At that point, generic competiti...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Participant must be a pharmaceutical entrepreneur as defined in §4(18) AMG with respect to the offered drug
- Must have a valid marketing authorization for Genvoya® or be otherwise entitled to place it on the market in Germany
- Seat must be in Germany, EU/EEA
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Originale Rabattverträge 2025-02- Elvitegravir/Cobicistat/Emtricitabin/Tenofoviralafenamidfumarat (Genvoya(R))
Single lot covering discount agreements for the fixed-dose combination Genvoya®. Contract duration max 24 months starting 01.03.2025, ends automatically at patent expiry or earlier.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria specified
any eligible participant meeting conditions can conclude a contract.
Value note
Show original TED data
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zur Wirkstoffkombination Elvitegravir/Cobicistat/Emtricitabin/Tenofoviralafenamidfumarat (Genvoya(R)) zu schließen.
Procurement Details
- Publication date
- 20 Jan 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 41398-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
15 / 100
Complexity
20 / 100
Risk factors
No estimated value, framework maximum, or lot values provided. Cannot estimate potential revenue.
Contract automatically ends upon patent expiry/loss of market exclusivity of Genvoya®. At that point, generic competiti...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications